MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, 6229 ER Maastricht, the Netherlands.
Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CG Utrecht, the Netherlands.
Comput Biol Med. 2021 Nov;138:104912. doi: 10.1016/j.compbiomed.2021.104912. Epub 2021 Oct 1.
Toxin removal by the kidney is deficient in a patient suffering from end-stage kidney disease (ESKD), and current dialysis therapies are insufficient in subsidizing this loss. A bioartificial kidney (BAK) aspires to offer ESKD patients a more effective alternative to dialysis. Mathematical models are necessary to support further developments and improve designs for the BAK before clinical trials. The BAK differentiates itself from dialysis by incorporating a living proximal tubule cell monolayer to account for the active transport of protein-bound uremic toxins, namely indoxyl sulfate (IS) in this study. Optimizing such a device is far from trivial due to the non-intuitive spatiotemporal dynamics of the IS removal process. This study used mathematical models to compare two types of active transport kinetics. i.e., two-step binding and lumped parameter. The modeling results indicated that the transporter density is the most influential parameter for the IS clearance. Moreover, a uniform distribution of transporters increases the IS clearance, highlighting the need for a high-quality, functional proximal tubule monolayer in the BAK. In summary, this study contributed to an improved understanding of IS transport in the BAK, which can be used along with laboratory experiments to develop promising renal replacement therapies in the future.
肾脏在患有终末期肾病(ESKD)的患者中去除毒素的能力不足,而目前的透析疗法在弥补这种损失方面还不够。生物人工肾(BAK)旨在为 ESKD 患者提供一种比透析更有效的替代方法。在临床试验之前,数学模型对于支持 BAK 的进一步发展和改进设计是必要的。BAK 通过整合活的近端肾小管细胞单层来区分自身与透析,以考虑到蛋白质结合尿毒症毒素(在本研究中为硫酸吲哚酚,IS)的主动转运。由于 IS 去除过程的非直观时空动力学,优化这样的设备绝非易事。本研究使用数学模型比较了两种主动转运动力学,即两步结合和集总参数。建模结果表明,转运体密度是影响 IS 清除率的最主要参数。此外,转运体的均匀分布增加了 IS 的清除率,突出了在 BAK 中需要高质量、功能性的近端肾小管单层。总之,本研究有助于更好地理解 BAK 中的 IS 转运,可与实验室实验一起用于未来开发有前途的肾脏替代疗法。